Market Tracker

03/24 5:16pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

5.87
Delayed Data
As of Mar 24
 -0.06 / -1.01%
Today’s Change
5.70
Today|||52-Week Range
10.51
-4.08%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close5.93
Today’s open5.95
Day’s range5.87 - 6.03
Volume16,225
Average volume (3 months)28,023
Market cap$78.0M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-29.85%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales142.00
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
GTXIGTX Inc-0.10-1.96%
ATNMActinium Pharmaceuti...-0.02-1.38%
ARQLArQule Inc-0.05-4.20%
LPCNLipocine Inc-0.17-4.07%
Data as of 4:02pm ET, 03/24/2017

Financials

Last reporting dateNovember 23, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$641.0K
Annual profit (last year)-$11.0M
Net profit margin-1,710.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts